Related Experiment Video
Updated: Jul 4, 2025

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
Published on: March 14, 2013
Evolution of LC-MS/MS in clinical laboratories
Songlin Yu1, Yutong Zou1, Xiaoli Ma1
1Department of Laboratory Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) offers clinical advantages but faces challenges in biomarker selection, automation, and standardization. Addressing these issues through utility-driven approaches and collaborative efforts will enhance its clinical integration.
Area of Science:
- Clinical Chemistry
- Analytical Chemistry
- Biomarker Discovery
Background:
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is increasingly recognized for its clinical utility.
- Widespread adoption is currently limited by challenges in analyte selection, automation, and standardization.
Purpose of the Study:
- To review the current challenges hindering the clinical application of LC-MS/MS.
- To propose potential resolutions for overcoming these limitations and facilitating broader adoption.
Main Methods:
- Comprehensive literature review of LC-MS/MS applications and challenges in clinical practice.
- Analysis of current limitations including analyte selection, automation, reference intervals, and quality control.
- Discussion of proposed solutions focusing on utility-driven biomarker selection, methodological innovation, standardization, and quality assurance.
Main Results:
- Key challenges identified include inappropriate biomarker selection, insufficient automation, lack of standardized reference intervals, and inadequate quality control programs.
- Proposed resolutions emphasize prioritizing practical utility in biomarker selection, developing high-throughput automation, establishing multi-center reference intervals, and creating commercial quality control materials.
- Harmonization and standardization efforts are crucial for clinical LC-MS/MS, with commercial kits and LDTs expected to coexist.
Conclusions:
- Addressing challenges in analyte selection, automation, and standardization is vital for the clinical integration of LC-MS/MS.
- Future advancements will focus on simplification, automation, intelligence, and standardization, enhancing its routine use for clinicians and technicians.
- Collaborative efforts among professionals are essential for the successful clinical implementation of LC-MS/MS.
More Related Videos
Related Concept Videos
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Mass Spectrometry: Complex Analysis
GC–MS is a powerful hyphenated method commonly used in forensics and environmental...
Tandem Mass Spectrometry
Secondary fragmentations occur in the interaction cell and can be induced by various factors. Fragmentation induced by collision with inert gases, such as N2, Ar, He, etc., is called collision-induced...
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Inductively Coupled Plasma–Mass Spectrometry (ICP–MS): Overview
Mass Spectrometers

